Patents by Inventor Hahk-Soo Kang

Hahk-Soo Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anticancer agents of the anthracyclin family
    Patent number: 9833465
    Abstract: Anthracyclin compounds of the general structure: are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2-R5 and R10-R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: December 5, 2017
    Assignee: The Rockefeller University
    Inventors: Sean Brady, Hahk-Soo Kang
  • ANTICANCER AGENTS OF THE ANTHRACYCLIN FAMILY
    Publication number: 20170189431
    Abstract: Anthracyclin compounds of the general structure: are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2-R5 and R10-R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
    Type: Application
    Filed: September 26, 2016
    Publication date: July 6, 2017
    Applicant: The Rockefeller University
    Inventors: Sean BRADY, Hahk-Soo Kang
  • Anticancer agents of the anthracyclin family
    Patent number: 9475834
    Abstract: Anthracyclin compounds of the general structure: are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2—R5 and R10—R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: October 25, 2016
    Assignee: The Rockefeller University
    Inventors: Sean Brady, Hahk-Soo Kang
  • ANTICANCER AGENTS OF THE ANTHRACYCLIN FAMILY
    Publication number: 20160068558
    Abstract: Anthracyclin compounds of the general structure: are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2—R5 and R10—R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
    Type: Application
    Filed: November 13, 2015
    Publication date: March 10, 2016
    Inventors: Sean BRADY, Hahk-Soo KANG
  • Anticancer agents of the anthracyclin family
    Patent number: 9217008
    Abstract: Anthracyclin compounds of the general structure: are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2-R5 and R10-R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: December 22, 2015
    Assignee: The Rockefeller University
    Inventors: Sean Brady, Hahk-Soo Kang